Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2014

01-04-2014 | Original Paper

Travel Distance to HIV Medical Care: A Geographic Analysis of Weighted Survey Data from the Medical Monitoring Project in Philadelphia, PA

Authors: M. G. Eberhart, C. D. Voytek, A. Hillier, D. S. Metzger, M. B. Blank, K. A. Brady

Published in: AIDS and Behavior | Issue 4/2014

Login to get access

Abstract

Decisions regarding where patients access HIV care are not well understood. The purpose of this analysis was to examine differences in travel distance to care among persons receiving care in Philadelphia. A multi-stage sampling design was utilized to identify 400 potential participants. 65 % (260/400) agreed to be interviewed. Participants were asked questions about medical care, supportive services, and geographic location. Distances were calculated between residence and care location. 46.3 % travelled more than three miles beyond the nearest facility. Uninsured travelled further (6.9 miles, 95 % CI 3.9–9.8) than persons with public insurance (3.3 miles, 2.9–3.6). In multivariate analyses, no insurance (20/260) was associated with increased distance (p = 0.0005) and Hispanic ethnicity was associated with decreased distance (p = 0.0462). Persons without insurance travel further but insurance status alone does not explain the variability in distance travelled to care. In Philadelphia, Hispanic populations, and providers that may be most accessible to them, are spatially contained.
Literature
1.
Allard SW, Tolman RM, Rosen D. Proximity to service providers and service utilization among welfare recipients: the interaction of place and race. J Policy Anal Manage. 2003;22(4):599–613.PubMedCrossRef
2.
Billi JE, Pai CW, Spahlinger DA. The effect of distance to primary care physician on health care utilization and disease burden. Health Care Manage Rev. 2007;32(1):22–9.PubMedCrossRef
3.
Huntington S, Chadborn T, Rice BD, Brown AE, Delpech VC. Travel for HIV care in England: a choice or a necessity? HIV Med. 2010;12:361–6.PubMedCrossRef
4.
Korthuis PT, Saha S, Fleishman JA, et al. Impact of patient race on patient experiences of access and communication in HIV care. J Gen Int Med. 2008;23(12):2046–52.CrossRef
5.
Leibowitz AA, Taylor SL. Distance to public test sites and HIV testing. Med Care Res Rev. 2007;64:568–84.PubMedCrossRef
6.
Moneyham L, McLeod J, Boehme A, et al. Perceived barriers to HIV care among HIV-infected women in the deep south. J Assoc Nurses AIDS Care. 2010;21(6):467–77.PubMedCrossRef
7.
Penniman TV, Taylor SL, Bird CE, Beckman R, Collins RL, Cunningham W. The associations of gender, sexual identity and competing needs with healthcare utilization among people with HIV/AIDS. J Nat Med Assoc. 2007;99(4):419–27.
8.
Pierce SJ, Miller RL, Morales MM, Forney J. Identifying HIV prevention service needs of African American men who have sex with men: an application of spatial analysis techniques to service planning. J Public Health Manage Pract. 2007;January (Supp):S72–9.CrossRef
9.
Higgs G. A literature review of the use of GIS-based measures of access to health care services. Health Serv Outcome Res Methodol. 2004;5:119–39.CrossRef
10.
Bliss RL, Katz JN, Wright EA, Losina E. Estimating proximity to care: are straight line and zipcode centroid distances acceptable proxy measures? Med Care. 2012;50(1):99–106.PubMedCentralPubMedCrossRef
11.
Kaukinen C, Fulcher C. Mapping the social demography and location of HIV services across Toronto neighbourhoods. Health Soc Care Community. 2006;14(1):37–48.PubMedCrossRef
12.
Caley LM. Using geographic information systems to design population-based interventions. Public Health Nurs. 2004;21(6):547–54.PubMedCrossRef
13.
Dubowitz T, Williams M, Steiner ED, et al. Using geographic information systems to match local health needs with public health services and programs. Am J Public Health. 2011;101(9):1664–5.PubMedCentralPubMedCrossRef
14.
Geanuracos CG, Cunningham SD, Weiss G, Forte D, Henry Reid LM, Ellen JM. Use of geographic information systems for planning HIV prevention interventions for high-risk youths. Am J Public Health. 2007;97(11):1974–81.PubMedCentralPubMedCrossRef
15.
Miranda ML, Silva JM, Overstreet Galeano MA, et al. Building geographic information system capacity in local health departments: lessons from a North Carolina project. Am J Public Health. 2005;95(12):2180–5.PubMedCentralPubMedCrossRef
16.
Whitman S, Silva A, Shah A, Ansel D. Diversity and disparity: GIS and small-area analysis in six Chicago neighbourhoods. J Med Syst. 2004;28(4):397–411.PubMedCrossRef
17.
Kandwal R, Garg PK, Garg RD. Health GIS and HIV/AIDS studies: perspective and retrospective. J Biomed Inform. 2009;42:748–55.PubMedCrossRef
18.
Law DCG, Serre ML, Christakos G, Leone PA, Miller WC. Spatial analysis and mapping of sexually transmitted diseases to optimize intervention and prevention strategies. Sex Transm Infect. 2004;80:294–9.PubMedCentralPubMedCrossRef
19.
Ramani KV, Mavalankar D, Patel A, Mehandiratta S. A GIS approach to plan and deliver healthcare services to urban poor. Int J Pharm Healthcare Market. 2007;1(2):159–73.CrossRef
20.
21.
Blair JM, McNaghten AD, Frazier EL, Skarbinski J, Huang P, Heffelfinger JD. CDC Clinical and behavioral characteristics of adults receiving medical care for HIV infection—medical monitoring project, United States, 2007. MMWR Surveill Summ. 2011;60(11):1–20.PubMed
22.
Frankel MR, McNaughton AD, Shapiro MF, et al. A probability sample for monitoring the HIV-infected population in care in the U.S. and in selected states. Open AIDS J. 2012;6:67–76.PubMedCentralPubMedCrossRef
23.
Bamford L, Ehrenkranz P, Eberhart M, Shpaner M, Brady K. Factors associated with delayed entry into primary HIV medical care after HIV diagnosis. AIDS. 2010;24(6):928–30.PubMedCrossRef
Metadata
Title
Travel Distance to HIV Medical Care: A Geographic Analysis of Weighted Survey Data from the Medical Monitoring Project in Philadelphia, PA
Authors
M. G. Eberhart
C. D. Voytek
A. Hillier
D. S. Metzger
M. B. Blank
K. A. Brady
Publication date
01-04-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0597-7

Other articles of this Issue 4/2014

AIDS and Behavior 4/2014 Go to the issue

Original Paper

Adapting the VOICES HIV Behavioral Intervention for Latino Men Who Have Sex with Men

Original Paper

Pregnant Women Living with HIV (WLH) Supported at Clinics by Peer WLH: A Cluster Randomized Controlled Trial

Original Paper

Cost-Effectiveness of a Package of Interventions for Expedited Antiretroviral Therapy Initiation During Pregnancy in Cape Town, South Africa

Original Paper

Marital Concurrency and HIV Risk in 16 African Countries

Editorial Review

Setting the Bar High or Setting Up to Fail? Interpretations and Implications of The EXPLORE Study (HPTN 015)

Original Paper

Methadone Maintenance Therapy Decreases the Rate of Antiretroviral Therapy Discontinuation Among HIV-Positive Illicit Drug Users
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits